According to the Company, the premixed bags were developed to reduce preparation time and the risk of preparation errors. Adrenalin premixed bags do not require further dilution prior to infusion.

Owkin has enticed another big pharma partner with its artificial intelligence-powered clinical development platform, Bristol-Myers Squibb, which is paying $80 million upfront to tap into its ...